Adobe Systems Inc vs Smith & Nephew plc — how do they compare? Adobe Systems Inc trades at $260.75 (market cap $104.82B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Adobe Systems Inc is far larger — about 8.4× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.65% dividend while Adobe Systems Inc pays none. Which is the better fit depends on your goals.
| ADBE | SNN | |
|---|---|---|
Market Cap | $104.82B | $12.54B |
Volume | 5,187,646 | — |
Sector | Technology | Health |
52-Week High | $367.46 | $38.70 |
52-Week Low | $193.41 | $28.73 |
Enterprise Value | $106.26B | $15.57B |
Dividend Yield | — | 2.65% |
Signals from Pluang's Aura AI — not financial advice
Adobe (ADBE) trades at $272.96, up 2.92% with strong technical momentum above key support at $270. The company demonstrates robust fundamentals with 2025 revenue of $23.77B and net income of $7.13B, maintaining exceptional profitability with 89.4% gross margins. Recent earnings beats and accelerating revenue growth contrast with mixed sentiment amid AI competition concerns and CEO transition uncertainty.
ADBE presents a compelling value proposition trading below analyst consensus targets with strong cash flow generation, though faces headwinds from AI disruption fears and sector volatility. The stock's current valuation at 15.62 P/E offers potential upside if execution continues, but requires monitoring of competitive threats and leadership stability.
No Aura AI signal available yet.
Trailing returns across standard periods
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →